For Research Use Only. Not for Human Consumption.
Recorded market$49.70Recorded exact-size market estimate: 49.70 USD for one 10 mg container (4.969804 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$49.00Member price$41.6016.2% lessMembers save $8.10 on this item vs. recorded market
Alpha-MSH analog for melanogenesis research.
Exact-size price research
Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. This reference uses recorded prices for the same 10 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$4.16/mg16.2% less
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 04:31 UTC. 1 x 10 mg = 10 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| TargetMol Oct 11, 2026 UTC | One 10 mg container; 129.00 USD | $12.90/mg | lyophilized powder; USA andGlobalInStock Price observation; no COA authentication is implied by inclusion. |
| American Biotech Oct 10, 2026 UTC | One 10 mg container; 39.99 USD | $4.00/mg | powder; in_stock Vector.store301redirecttoAmericanBiotech; actualdomaincountedonce. Public1vial39.99USD10mglyophilizedpowder. Price observation; no COA authentication is implied by inclusion. |
| PSPeptides Oct 10, 2026 UTC | One 10 mg container; 39.99 USD | $4.00/mg | powder; in_stock Selected10MG1bottle39.99USD;explicitonevial10mglyophilizedpowder. Price observation; no COA authentication is implied by inclusion. |
| Bergdorf Bioscience Oct 10, 2026 UTC | One 10 mg container; 69.99 USD | $7.00/mg | powder; in_stock USchannelUSD69.99,selected1pcs10mglyophilizedsealedvial. Quantitydiscountsexcluded. Price observation; no COA authentication is implied by inclusion. |
| Bluum Peptides Oct 10, 2026 UTC | One 10 mg container; 39.00 USD | $3.90/mg | powder; in_stock Buy1standard10mgvial39USDJSONLD;explicitpowderin3mLglassvial.Agequestionunanswered. Price observation; no COA authentication is implied by inclusion. |
| Luxe Peptides Oct 10, 2026 UTC | One 10 mg container; 40.00 USD | $4.00/mg | powder; in_stock Only10mgsize,40USDpervial glasspowder explicit;qty1. Buy2get1promoexcluded. Price observation; no COA authentication is implied by inclusion. |
| Pepta Labs Oct 10, 2026 UTC | One 10 mg container; 25.89 USD | $2.59/mg | powder; in_stock Explicit1vial25.89USD10mgsealedpowdervial;checkoutaccountrequirementdoesnotgatepublicprice. FALL25/crypto5%excluded. Price observation; no COA authentication is implied by inclusion. |
| Core Peptides Oct 11, 2026 UTC | One 10 mg container; 43.00 USD | $4.30/mg | powder; in_stock Public43USD, exact10mglyophpowder. Retailqty1, singlevialphoto, no kit/minimum; discountstarts5. Standalonevialinterpretation. Price observation; no COA authentication is implied by inclusion. |
| Melanotan Express Oct 11, 2026 UTC | One 10 mg container; 35.25 USD | $3.53/mg | lyophilized powder; in_stock Price observation; no COA authentication is implied by inclusion. |
| Healius Peptides Oct 11, 2026 UTC | One 10 mg container; 49.95 AUD | $3.49/mg | lyophilized powder; publicly_listed Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “Melanotan 1 – 10 mg | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/melanotan-1-10-mg/ Accessed [your access date].
Source page: https://peptideserum.com/product/melanotan-1-10-mg/
A linear alpha-MSH analog studied in laboratory models of melanocortin signaling and pigmentation biology.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
Afamelanotide, also called Melanotan I, is used in an approved implant for adults with erythropoietic protoporphyria. This does not approve online tanning preparations.
The National Cancer Institute lists Melanotan I as a synonym for afamelanotide. It is distinct from the cyclic Melanotan II molecule and from bremelanotide.
Scenesse is a defined prescription implant. Formulation and release properties are part of that product, not a minor detail that can be removed when discussing the evidence.
The strongest reviewed evidence comes from two controlled trials in adults with erythropoietic protoporphyria, a condition involving painful light reactions. The outcome was pain-free light exposure in this population. Cosmetic tanning, prevention of skin cancer and treatment with an unspecified powder are different questions.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Afamelanotide for Erythropoietic Protoporphyria
Two multicenter randomized double-blind placebo-controlled implant trials, with 74 European and 94 US participants Reading scope: PubMed abstract |
Afamelanotide increased pain-free sunlight exposure and improved quality-of-life measures in adults with erythropoietic protoporphyria. | The trials concern a particular implant and diagnosed population, not general cosmetic use or an interchangeable injectable preparation. |
| Increased eumelanin expression and tanning is induced by a superpotent melanotropin in humans
Early human pigmentation and skin-biopsy study of Melanotan I Reading scope: PubMed abstract excerpt |
Pigmentation changes were observed at several assessed sites, with biochemical measurements of skin pigment. | Pigmentation is not evidence of prevention of skin cancer or a demonstration that ultraviolet exposure becomes harmless. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
The benefit established for a rare phototoxic disorder should not be broadened into a general safe-tanning promise. An outcome measured in hours of tolerated light exposure also differs from a claim about long-term skin damage.
Older studies may use different routes from the approved implant. A shared ingredient does not establish equal exposure, duration or risk.
Product approval and chemical identity are separate facts. A laboratory may identify afamelanotide in a sample without establishing that the sample is Scenesse or satisfies the approved product specifications.
The current Scenesse label warns about serious hypersensitivity and darkening of existing nevi or freckles, with skin monitoring. It continues to advise sun and light protection. Pigmentation is not permission to increase harmful exposure.
A controlled-release implant cannot be compared with a powder by simply matching milligrams. Release, route and administration setting shape exposure.
Read historical pigmentation studies as research protocols, not as cosmetic tanning schedules. Their designs do not justify copying or converting exposures.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Verify the exact afamelanotide identity rather than a generic melanotan label. Distinguish ingredient documentation from authenticated packaging and supply records for the prescription implant.
Check whether a cited clinical paper used an implant or another preparation. If the offered material differs, that difference belongs beside the claimed benefit.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. They are different molecules with different evidence and formulations. An approval involving afamelanotide cannot be transferred to Melanotan II.
Increasing pain-free light exposure in adults with a history of phototoxic reactions from erythropoietic protoporphyria, using the specified implant.
No. The cited pigmentation study does not establish a general sun-protection factor or skin-cancer prevention.
This companion to the Melanotan I / Afamelanotide research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
A controlled-release implant cannot be compared with a powder by simply matching milligrams. Release, route and administration setting shape exposure.
Read historical pigmentation studies as research protocols, not as cosmetic tanning schedules. Their designs do not justify copying or converting exposures.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Read the full Melanotan I / Afamelanotide profile and sources
Reviews
There are no reviews yet.